MED9 anticorps
-
- Antigène Voir toutes MED9 Anticorps
- MED9 (Mediator Complex Subunit 9 (MED9))
-
Reactivité
- Humain, Souris, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp MED9 est non-conjugé
-
Application
- Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Purification
- Antigen affinity purified
- Immunogène
- A recombinant human protein corresponding to amino acids A55-E146 was used as the immunogen for the MED9 antibody.
- Isotype
- IgG
- Top Product
- Discover our top product MED9 Anticorps primaire
-
-
- Indications d'application
- Optimal dilution of the MED9 antibody should be determined by the researcher.\. Western Blot: 0.5-1 μg/mL,IHC (FFPE): 1-2 μg/mL,Direct ELISA (recombinant human protein): 0.1-0.5 μg/mL (BSA-free format available)
- Restrictions
- For Research Use only
-
- Buffer
- 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water
- Stock
- -20 °C
- Stockage commentaire
- After reconstitution, the MED9 antibody can be stored for up to one month at 4°C. For long-term, aliquot and store at -20°C. Avoid repeated freezing and thawing.
-
- Antigène
- MED9 (Mediator Complex Subunit 9 (MED9))
- Autre désignation
- MED9 / MED25 (MED9 Produits)
- Synonymes
- anticorps MED25, anticorps BC019367, anticorps Med25, anticorps mediator complex subunit 9, anticorps mediator complex subunit 9 L homeolog, anticorps MED9, anticorps med9.L, anticorps Med9
- Sujet
- MED9 is a member of the mediator complex of proteins that promote activation of RNA polymerase II through direct interactions with transcription factors. This MED9 gene is located within the Smith-Magenis syndrome region on chromosome 17.
- UniProt
- Q9NWA0
- Pathways
- Regulation of Lipid Metabolism by PPARalpha
-